Novo Nordisk (NVO) warns U.S. tariffs on pharmaceuticals may lead to drug shortages & price hikes. Read more here.

Hi, it’s Ike in Boston. We’ve gotten some more insight into the ADHD drug shortages, which have been going on for over two ...

U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could ...

Cost Plus Drugs inked deals with MultiCare Health System, Network Health, Blue Cross and Blue Shield insurers and others ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients without insurance.

Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...

Under the Inflation Reduction Act’s price-fixing model, small molecule drugs are eligible for selection to the “Medicare Drug Price Negotiation” program 7 years after FDA approval, followed by a ...

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is ...

About 90% of the drugs Americans consume are generic, and a vast majority of those are at least partly manufactured overseas.